×
Medtronic Inventory 2010-2024 | MDT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Medtronic inventory for the quarter ending July 31, 2024 was
$5.414B
, a
4.48% decline
year-over-year.
Medtronic inventory for 2024 was
$5.217B
, a
1.44% decline
from 2023.
Medtronic inventory for 2023 was
$5.293B
, a
14.67% increase
from 2022.
Medtronic inventory for 2022 was
$4.616B
, a
7.03% increase
from 2021.
View More
Medtronic Inventory 2010-2024 | MDT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Medtronic inventory for 2024 was
$5.217B
, a
1.44% decline
from 2023.
Medtronic inventory for 2023 was
$5.293B
, a
14.67% increase
from 2022.
Medtronic inventory for 2022 was
$4.616B
, a
7.03% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$199.9B
Stryker (SYK)
$137.7B
Boston Scientific (BSX)
$121.6B
EssilorLuxottica (ESLOY)
$104.4B
Haleon (HLN)
$48.1B
Lonza Group Ag (LZAGY)
$45.4B
ResMed (RMD)
$35B
Koninklijke Philips (PHG)
$29B
Terumo (TRUMY)
$27.9B
Zimmer Biomet Holdings (ZBH)
$21.6B
Baxter (BAX)
$20.1B
Insulet (PODD)
$16.6B
Smith & Nephew SNATS (SNN)
$13.4B
Bio-Rad Laboratories (BIO)
$9.5B
Demant (WILYY)
$9.2B
BellRing Brands (BRBR)
$7.7B
Lantheus Holdings (LNTH)
$7.5B
ICU Medical (ICUI)
$4.3B
TG Therapeutics (TGTX)
$3.9B
Haemonetics (HAE)
$3.9B
Perrigo (PRGO)
$3.8B
GN Store Nord (GNNDY)
$3.8B
Neogen (NEOG)
$3.7B
Prestige Consumer Healthcare (PBH)
$3.6B
Envista Holdings (NVST)
$3.3B
QuidelOrtho (QDEL)
$3.1B
Agios Pharmaceuticals (AGIO)
$2.6B
Maravai LifeSciences Holdings (MRVI)
$2.3B
Green Thumb Industries (GTBIF)
$2.2B
LeMaitre Vascular (LMAT)
$2B